To understand the role of cytokines during rotavirus infection, we assessed the kinetics of tumor necrosis factor alpha (TNF-␣) and interleukin-6 (IL-6) (proinflammatory) ,

Group A rotaviruses are the most common cause of dehydrating diarrhea in infants and young children worldwide, with more than 2 million hospitalizations yearly and approximately 440,000 deaths. It is estimated that 82% of rotavirus deaths occur in children in the poorest countries (23). Rotavirus transmission occurs mainly by the fecal-oral route, although respiratory transmission has been suggested to occur (7).Rotavirus infection was thought to be limited to the gastrointestinal tract. However, respiratory symptoms and rotavirus shedding in nasopharyngeal secretions have been reported in children with and without gastrointestinal symptoms (19,26,42). Rotavirus antigen was detected in the lung of 1 of 13 experimentally infected 3-week-old conventional pigs at postinoculation day 2 (30) and in liver and kidney specimens from immunodeficient children (9). Rotavirus RNA has also been detected in cerebrospinal fluid and blood of children with central nervous system disease (20,34). Recently, Blutt and colleagues (2) detected rotavirus antigenemia in the serum of children, mice, rabbits, and calves. They further demonstrated that serum from infected mice induced rectal rotavirus antigen shedding after oral inoculation of rotavirus-negative adult mice with the serum. Previously, another enteric virus, the porcine enteric calicivirus (PEC), has also been associated with transient viremia (infectious virus in serum) after oral inoculation of gnotobiotic pigs (11).We choose gnotobiotic pigs because they constitute an animal model of HRV-induced disease. Their gastrointestinal tract physiology and their development of mucosal immunity resemble that of humans. These similarities with HRV infections of infants allow us to establish correlations which could be applied for rotavirus vaccine development (14,25) The question addressed in our study was whether an attenuated human rotavirus and virulent HRV causes upper respiratory tract infections or viremia in naïve neonatal gnotobiotic pigs after various routes of inoculation. In this study we evaluated nasal and rectal virus shedding and viremia after oral, intranasal, feeding tube (gavage), and intravenous inoculation of neonatal gnotobiotic pigs with the Wa strain of attenuated HRV or virulent HRV. The presence of infectious virus in serum of gnotobiotic pigs after oral inoculation with Wa HRV was also investigated by oral and intravenous reinoculation of gnotobiotic pigs with a pool of the HRV-positive sera. MATERIALS AND METHODSVirus. The attenuated cell culture-adapted Wa strain HRV (P1A [8]G1), derived from the 27th HRV passage in African Green monkey kidney cells (MA104) and the virulent Wa HRV from pooled intestinal contents of gnotobiotic pigs were used for inoculation of the gnotobiotic pigs at doses of 5 ϫ 10 7

Background Malignant bowel obstruction is a common result of end-stage abdominal cancer that is a treatment dilemma for many physicians. Little has been reported predicting outcomes or determining the role of surgical intervention. We sought to review our experience with surgical and nonsurgical management of malignant bowel obstruction to identify predictors of 30-day mortality and of who would most likely benefit from surgical intervention. Methods A chart review of 523 patients treated between 2000 and 2007 with malignant bowel obstruction were evaluated for factors present at admission to determine return to oral intake, 30-day mortality, and overall survival. Propensity score matching was used to homogenize patients treated with and without surgery to identify those who would benefit most from operative intervention. Results Radiographic evidence of large bowel obstruction was predictive of return to oral intake. Hypoalbuminemia and radiographic evidence of ascites or carcinomatosis were all predictive of increased 30-day mortality and overall survival. A nomogram of 5 identified risk factors correlated with increased 30-day mortality independent of therapy. Patients with large bowel or partial small bowel obstruction benefited most from surgery. A second nomogram was created from 4 identified risk factors that revealed which patients with complete small bowel obstruction might benefit from surgery. Conclusion Two nomograms were created that may guide decisions in the care of patients with malignant bowel obstruction. These nomograms are able to predict 30-day mortality and who may benefit from surgery for small bowel obstruction.

Fibrosis can develop in the HA-RD model. There is an upregulation of select MMPs that may modulate the wound healing process following RD.

PURPOSE. The probability of type I error, or a false-positive result, increases as the number of statistical comparisons in a study increases. Statisticians have developed numerous corrections to account for the multiple comparison problem. This study discusses recent guidelines involving multiple comparison corrections, calculates the prevalence of corrections in ophthalmic research, and estimates the corresponding number of false-positive results reported at a recent international research meeting.METHODS. The 6415 abstracts presented at ARVO 2010 were searched for statistical comparisons (P values) and for use of multiple comparison corrections. Studies that reported five or more P values while reporting no correction factor were used in a simulation study. The simulation study was conducted to estimate the number of false-positive results reported in these studies.RESULTS. Overall, 36% of abstracts reported P values and 1.2% of abstracts used some form of correction. Whereas 8% of abstracts reported at least five P values, only 5% of these used a multiple comparison correction. In these highly statistical studies, simulations resulted in 185 false-positive outcomes found in 30% of abstracts.CONCLUSIONS. The paucity of multiple comparison corrections in ophthalmic research results in inflated type I error and may produce unwarranted shifts in clinical or surgical care. Researchers must make a conscious effort to decide if and when to use a correction factor to ensure the validity of the data. (Invest Ophthalmol Vis Sci.